[How to Classify and Evaluate Complementary and Alternative Medicines in Oncology]

Area of Science:

• Oncology
• Integrative Medicine
• Evidence-Based Practice

Background:

• Growing patient interest in complementary and alternative medicines (CAM) in cancer care.
• Challenges in classifying and evaluating the efficacy and safety of numerous CAM options.
• Need for patient-centered information to support informed decision-making regarding CAM.

Purpose of the Study:

• To develop a structured framework for assessing the benefit-risk profile of CAM in oncology.
• To provide a method for evaluating CAM based on scientific evidence and individual patient characteristics.
• To aid cancer patients in making informed choices about complementary therapies.

Main Methods:

• Development of a benefit-risk assessment model.
• Integration of evidence-based medicine principles.
• Consideration of individual patient therapeutic goals and health status.

Main Results:

• The assessment framework evaluates CAM benefits by considering scientific evidence and patient goals.
• Risk assessment incorporates the nature of the CAM method and the patient's specific health condition.
• The approach facilitates a personalized evaluation of CAM options for cancer patients.

Conclusions:

• A systematic benefit-risk assessment is crucial for navigating CAM in oncology.
• Personalized evaluation, integrating evidence and patient factors, enhances safe and effective CAM use.
• The developed framework supports informed decision-making for cancer patients exploring complementary therapies.